Milestone Pharmaceuticals
MIST
MIST
23 hedge funds and large institutions have $240M invested in Milestone Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
32% less capital invested
Capital invested by funds: $350M → $240M (-$111M)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
23
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$4.85M | |
| 2 | +$627K | |
| 3 | +$420K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$12.1K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$3.73K |
Top Sellers
| 1 | -$6.79M | |
| 2 | -$1.06M | |
| 3 | -$459K | |
| 4 |
Millennium Management
New York
|
-$182K |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$93.3K |